PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1983 October; 76(10): 848–852.
PMCID: PMC1439615

Combined effects of radiation and methotrexate on the cells of the rat subependymal plate.

Abstract

The brains of 20-week-old rats were locally irradiated with single doses of X-rays (400-1400 cGy). A similar group of animals received an intraventricular injection of methotrexate (MTX) prior to irradiation with single doses of X-rays (600-1400 cGy). Animals were killed six weeks after irradiation. A group of unirradiated age-matched animals acted as controls. In irradiated animals, the most severe effect on the subependymal plate (SEP) of the brain was denoted by the fall in the mitotic count (MC) and the number of small dark (SD) nucleated cells. SD nucleated cells are believed to represent the proliferative compartment of the subependymal layer. Other cell types in the SEP, believed to arise from the SD nucleated population, were affected to a lesser degree. After combination treatment with MTX, the decline in the MC and the SD nuclear density was more severe. The data for the dose-related decline in SD nuclear density and the MC fitted equally well on log-linear and linear plots. From the log-linear plots of the data it was concluded that MTX was radiation dose modifying (DMF 1.25-1.44). However, on the basis of the linear plots the effect of radiation and MTX was apparently additive. While no firm conclusions could be drawn regarding the mechanism of action of MTX on the radiation response of SEP cells, the possible mechanisms are discussed.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (586K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abelson HT. Methotrexate and central nervous system toxicity. Cancer Treat Rep. 1978 Dec;62(12):1999–2001. [PubMed]
  • Back EH. Death after intrathecal methotrexate. Lancet. 1969 Nov 8;2(7628):1005–1005. [PubMed]
  • Berry RJ, Huckle JM. Radiation and methotrexate effects on stationary phase cells. Br J Radiol. 1972 Sep;45(537):710–711. [PubMed]
  • BERTINO JR, BOOTH BA, BIEBER AL, CASHMORE A, SARTORELLI AC. STUDIES ON THE INHIBITION OF DIHYDROFOLATE REDUCTASE BY THE FOLATE ANTAGONISTS. J Biol Chem. 1964 Feb;239:479–485. [PubMed]
  • Cavanagh JB, Lewis PD. Perfusion-fixation, colchicine and mitotic activity in the adult rat brain. J Anat. 1969 Mar;104(Pt 2):341–350. [PubMed]
  • Chabner BA, Young RC. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues. J Clin Invest. 1973 Aug;52(8):1804–1811. [PMC free article] [PubMed]
  • Freeman JE, Johnston PG, Voke JM. Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia. Br Med J. 1973 Dec 1;4(5891):523–525. [PMC free article] [PubMed]
  • Griffin TW, Rasey JS, Bleyer WA. The effect of photon irradiation on blood-brain barrier permeability to methotrexate in mice. Cancer. 1977 Sep;40(3):1109–1111. [PubMed]
  • HAMILTON L, ELION GB. The fate of 6-mercaptopurine in man. Ann N Y Acad Sci. 1954 Dec 6;60(2):304–314. [PubMed]
  • Hopewell JW, Cavanagh JB. Effects of X irradiation on the mitotic activity of the subependymal plate of rats. Br J Radiol. 1972 Jun;45(534):461–465. [PubMed]
  • Hopewell JW, Wright EA. The nature of latent cerebral irradiation damage and its modification by hypertension. Br J Radiol. 1970 Mar;43(507):161–167. [PubMed]
  • Hubbard BM, Hopewell JW. Quantitative changes in the cellularity of the rat subependymal plate after X-irradiation. Cell Tissue Kinet. 1980 Jul;13(4):403–413. [PubMed]
  • Hustu HO, Aur RJ, Verzosa MS, Simone JV, Pinkel D. Prevention of central nervous system leukemia by irradiation. Cancer. 1973 Sep;32(3):585–597. [PubMed]
  • Lewis PD. A quantitative study of cell proliferation in the subependymal layer of the adult rat brain. Exp Neurol. 1968 Feb;20(2):203–207. [PubMed]
  • PIKE MC, ALPER T. A METHOD FOR DETERMINING DOSE-MODIFICATION FACTORS. Br J Radiol. 1964 Jun;37:458–462. [PubMed]
  • Pinkel D, Hustu HO, Aur RJ, Smith K, Borella LD, Simone J. Radiotherapy in leukemia and lymphoma of children. Cancer. 1977 Feb;39(2 Suppl):817–824. [PubMed]
  • Rubinstein LJ, Herman MM, Long TF, Wilbur JR. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer. 1975 Feb;35(2):291–305. [PubMed]
  • Shehata WM, Meyer RL. The enhancement effect of irradiation by methotrexate. Report of three complications. Cancer. 1980 Sep 15;46(6):1349–1352. [PubMed]
  • SULLIVAN MP. Intracranial complications of leukemia in children. Pediatrics. 1957 Nov;20(5 Pt 1):757–781. [PubMed]
  • WHITESIDE JA, PHILIPS FS, DARGEON HW, BURCHENAL JH. Intrathecal amethopterin in neurological manifestations of leukemia. AMA Arch Intern Med. 1958 Feb;101(2):279–285. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press